AHNAK controls 53BP1-mediated p53 response by restraining 53BP1 oligomerization and phase separation
Open Access
- 1 June 2021
- journal article
- research article
- Published by Elsevier in Molecular Cell
- Vol. 81 (12) , 2596-2610.e7
Abstract
No abstract availableKeywords
Funding Information
- European Research Council
This publication has 58 references indexed in Scilit:
- Ahnak scaffolds p11/Anxa2 complex and L-type voltage-gated calcium channel and modulates depressive behaviorMolecular Psychiatry, 2019
- Inherited DNA lesions determine G1 duration in the next cell cycleCell Cycle, 2017
- DNA damage during S-phase mediates the proliferation-quiescence decision in the subsequent G1 via p21 expressionNature Communications, 2017
- AHNAK as a Prognosis Factor Suppresses the Tumor Progression in GliomaJournal of Cancer, 2017
- DPY30 regulates pathways in cellular senescence through ID protein expressionThe EMBO Journal, 2013
- Azithromycin Synergistically Enhances Anti-Proliferative Activity of Vincristine in Cervical and Gastric Cancer CellsCancers, 2012
- New Insights into p53 Signaling and Cancer Cell Response to DNA Damage: Implications for Cancer TherapyJournal of Biomedicine and Biotechnology, 2012
- 53BP1 nuclear bodies form around DNA lesions generated by mitotic transmission of chromosomes under replication stressNature Cell Biology, 2011
- The p53 response to DNA damageDNA Repair, 2004
- In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2Science, 2004